Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Promoting Smoking Cessation for Female Smokers in Hong Kong Through Training Female Youth SCRA

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02755740
Recruitment Status : Completed
First Posted : April 29, 2016
Last Update Posted : October 26, 2017
Sponsor:
Information provided by (Responsible Party):
Dr. LI William Ho Cheung, The University of Hong Kong

Brief Summary:

This project aims to promote quitting, and reduction for those who do not want to quit, among female smokers through training female youth as smoking cessation and reduction ambassadors (SCRA). The objectives are to:

  1. Promote age and gender-specific smoking cessation and reduction to the female population
  2. Deliver a smoking cessation and reduction ambassador training workshop to equip and empower female youth with the knowledge on the adverse effects of smoking on female smokers and the skills in smoking cessation and reduction and in raising public awareness of the harmful effects of smoking on female smokers.
  3. Have the trained female youth to deliver a brief advice (AWARD) to female smokers to help them to quit or reduce smoking and refer them to the female-specific smoking cessation hotline or the Department of Health Quitline for further assistance if needed.

Condition or disease Intervention/treatment Phase
Smoking Cessation Other: receiving age and gender-specific SC advice Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Promoting Smoking Cessation for Female Smokers in Hong Kong Through Training Female Youth Smoking Cessation and Reduction Ambassadors (SCRA)
Study Start Date : July 2015
Actual Primary Completion Date : May 2017
Actual Study Completion Date : August 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
receiving age and gender-specific SC advice
After delivering the "AWARD" advice, the trained SCRA will seek consent from and refer adult female smokers (aged over 25 years) to our intensive smoking cessation telephone or face-to-face counselling interventions, which has already counselled 509 female smokers with a quit rate of 29.7% at 6-month and 26.7% at 3-year follow up. Female youth smokers will give consent and be referred to our Youth Quitline (5111 4333), a smoking cessation telephone counselling for young people aged 25 or below which has counselled 1257 smokers with a quit rate of 21.9% at 6 months. If necessary, the female smokers can be referred to other smoking cessation services (e.g., the integrated smoking cessation hotline by the Department of Health (1833-183).
Other: receiving age and gender-specific SC advice
After delivering the "AWARD" advice, the trained SCRA will seek consent from and refer adult female smokers (aged over 25 years) to our intensive smoking cessation telephone or face-to-face counselling interventions, which has already counselled 509 female smokers with a quit rate of 29.7% at 6-month and 26.7% at 3-year follow up. Female youth smokers will give consent and be referred to our Youth Quitline (5111 4333), a smoking cessation telephone counselling for young people aged 25 or below which has counselled 1257 smokers with a quit rate of 21.9% at 6 months. If necessary, the female smokers can be referred to other smoking cessation services (e.g., the integrated smoking cessation hotline by the Department of Health (1833-183).




Primary Outcome Measures :
  1. The self-reported quit rate [ Time Frame: 6-month follow-up ]
    not smoke for at least 7 days


Secondary Outcome Measures :
  1. biochemical-validated quit rate [ Time Frame: 6-month follow-up ]
    measurement of exhaled (CO) and salivary cotinine level

  2. smoking reduction rate [ Time Frame: 1-, 3-, and 6-month follow-up ]
  3. smoking quit attempt [ Time Frame: 1-, 3-, and 6-month follow-up ]
  4. KAP change of SCRA from baseline to 3- and 6-month follow-up [ Time Frame: 3- and 6-month follow-up ]
    Use questionnaires to measure the change of smoking cessation and reduction-related knowledge, attitudes and practice of Smoking Cessation Ambassadors.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • be able to communicate with Cantonese

Exclusion Criteria:

  • taking Psychiatric drugs

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02755740


Locations
Layout table for location information
China
The University of Hong Kong
Hong Kong, China
Sponsors and Collaborators
The University of Hong Kong
Investigators
Layout table for investigator information
Principal Investigator: William LI, Phd School of Nursing, the University of Hong Kong

Layout table for additonal information
Responsible Party: Dr. LI William Ho Cheung, Associate Professor, The University of Hong Kong
ClinicalTrials.gov Identifier: NCT02755740     History of Changes
Other Study ID Numbers: Girl Guide
First Posted: April 29, 2016    Key Record Dates
Last Update Posted: October 26, 2017
Last Verified: October 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Dr. LI William Ho Cheung, The University of Hong Kong:
female